Leukemia, lymphoma, and multiple myeloma are all types of blood cancers, but they affect different types of blood cells and have unique characteristics. Leukemia involves the rapid growth of abnormal white blood cells, lymphoma affects lymphocytes, and myeloma affects plasma cells, which produce antibodies.
With the recent expansion on Lymphoma to include “in remission,” it’s important to understand when to use “history of” versus “in remission.”
From a coding professional’s perspective, if the physician’s documentation states “history of” or the site of disease has been eradicated, treatment has been completed, and the patient is declared “cancer free,” we use the “history of” codes. Alternatively, if the patient is documented as having achieved complete remission or partial remission, we would use the “in remission” code.
The National Cancer Institute defines in remission as: “A decrease in or disappearance of signs or symptoms of cancer. Partial remission, some but not all signs and symptoms of cancer have disappeared. Complete remission, all signs and symptoms of cancer have disappeared, although cancer still may be in the body.”[i]
Are there any other terms that we can look for to indicate when to use “in remission” other than “remission”?
The University of Texas MD Anderson Cancer Center published an article entitled, “Remission, cancer-free, no evidence of disease: What’s the difference?” And they explained that “remission” and “no evidence of disease,” also known or abbreviated as NED, both mean that no cancer is currently detectable in the body. This may be based on scans, bloodwork, or other tests.[ii]
“Cancer free” terminology implies there is no residual cancer left anywhere, thus is now considered “personal history.” In using this information, coding professionals could draw a link between documented “no evidence of disease” and “in remission.”
The American Hospital Association’s (AHA’s) Coding Clinic 2024, 4th Qtr. suggests that using “no evidence of disease” also equates to “in remission.” It further states: ” The focus of lymphoma treatment is to induce complete remission by destroying lymphoma cells.
Complete remission means that all evidence of disease has been eliminated.” This is your NED. Of course, if the documentation is unclear whether the lymphoma, leukemia, or myeloma is “in remission” or “history of,” a query should be sent to the physician.
ICD-10-CM Official Guidelines for Coding and Reporting Section I.C.2.g.l.n. ends by stating, “If the documentation is unclear as to whether the leukemia has achieved remission, the provider should be queried.”[iii]
Is there any value in using the “in remission” code instead of the “history of” code. Yes! “In remission” will impact the DRG by adding a complication or comorbidity (CC) to the case. And in the cases where APR/DRGs are being used, the “in remission” code can carry weight, which, in turn, can impact the severity of illness (SOI) or risk of mortality (ROM). Using the “history of” codes do not have the same impact.
This, in turn, provides clinical documentation integrity (CDI)departments with an opportunity to educate providers in the importance of having clear and concise documentation and how it may impact the bottom line. Having clarity in the use of “history of” versus “in remission” allows coders to be precise in their coding activities.
Programming note:
Listen to Amy Jo Combs report this story live today during Talk Ten Tuesday with Chuck Buck and Angela Comfort, 10 Eastern.
[i] National Cancer Institute. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/remission
[ii] Demarco, C. Remission, cancer-free, no evidence of disease: What’s the difference? 5/12/21. https://www.mdanderson.org/cancerwise/remission–cancer-free–no-evidence-of-disease–what-is-the-difference-when-talking-about-cancer-treatment-effectiveness-and-results.h00-159460845.html
[iii] CD-10-CM Official Guidelines for Coding and Reporting. 2017. https://www.cms.gov/medicare/coding/icd10/downloads/2017-icd-10-cm-guidelines.pdf
Other resources: Bredehoeft, E. Clear Up Confusion as to When Cancer Becomes “History of.” November 1, 2017. AAPC Knowledge Center. https://www.aapc.com/blog/40016-clear-up-confusion-as-to-when-cancer-becomes-history-of/?msockid=27f4c9a5238363931ad6dc6f22086263
With so much focus within the federal government on abuse, fraud, and waste, I thought it might be helpful to review a couple of federal
Following the release of the Centers for Medicare & Medicaid Services (CMS) proposed Physician Fee Schedule (PFS) for 2026, outpatient evaluation and management (E&M) coding
Please log in to your account to comment on this article.
Denials continue to delay reimbursement, increase administrative burden, and threaten financial stability across healthcare organizations. This essential webcast tackles the root causes—rising payer scrutiny, fragmented workflows, inconsistent documentation, and underused analytics—and offers proven, data-driven strategies to prevent and overturn denials. Attendees will gain practical tools to strengthen documentation and coding accuracy, engage clinicians effectively, and leverage predictive analytics and AI to identify risks before they impact revenue. Through real-world case examples and actionable guidance, this session empowers coding, CDI, and revenue cycle professionals to shift from reactive appeals to proactive denial prevention and revenue protection.
Sepsis remains one of the most frequently denied and contested diagnoses, creating costly revenue loss and compliance risks. In this webcast, Angela Comfort, DBA, MBA, RHIA, CDIP, CCS, CCS-P, provides practical, real-world strategies to align documentation with coding guidelines, reconcile Sepsis-2 and Sepsis-3 definitions, and apply compliant queries. You’ll learn how to identify and address documentation gaps, strengthen provider engagement, and defend diagnoses against payer scrutiny—equipping you to protect reimbursement, improve SOI/ROM capture, and reduce audit vulnerability in this high-risk area.
Only ICD10monitor delivers what you need: updates on must-know changes associated with the FY26 IPPS, including new ICD-10-CM/PCS codes, CCs/MCCs, and MS-DRGs, plus insights, analysis and answers to your questions from two of the country’s most respected subject matter experts.
This third session in our 2026 IPPS Masterclass will feature a review of FY26 changes to the MS-DRG methodology and new technology add-on payments (NTAPs), presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.
Federal auditors are zeroing in on Inpatient Rehabilitation Facility (IRF) and hospital rehab unit services, with OIG and CERT audits leading to millions in penalties—often due to documentation and administrative errors, not quality of care. Join compliance expert Michael Calahan, PA, MBA, to learn the five clinical “pillars” of IRF-PPS admissions, key documentation requirements, and real-life case lessons to help protect your revenue.
During this essential RACmonitor webcast Michael Calahan, PA, MBA Certified Compliance Officer, will clarify the rules, dispel common misconceptions, and equip you with practical strategies to code, document, and bill high-risk split/shared, incident-to & critical care E/M services with confidence. Don’t let audit risks or revenue losses catch your organization off guard — learn exactly what federal auditors are looking for and how to ensure your documentation and reporting stand up to scrutiny.
Learn how to navigate the proposed elimination of the Inpatient-Only list. Gain strategies to assess admission status, avoid denials, protect compliance, and address impacts across Medicare and non-Medicare payors. Essential insights for hospitals.
RACmonitor is proud to welcome back Dr. Ronald Hirsch, one of his most requested webcasts. In this highly anticipated session, Dr. Hirsch will break down the complex Two Midnight Rule Medicare regulations, translating them into clear, actionable guidance. He’ll walk you through the basics of the rule, offer expert interpretation, and apply the rule to real-world clinical scenarios—so you leave with greater clarity, confidence, and the tools to ensure compliance.
Prepare for the 2025 CMS IPPS Final Rule with ICD10monitor’s IPPSPalooza! Click HERE to learn more
Get 15% OFF on all educational webcasts at ICD10monitor with code JULYFOURTH24 until July 4, 2024—start learning today!
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
